In the bloodstream, T cells in the setting of early lung carcinoma also express immune-regulatory markers such as the checkpoint inhibitor PD1 on CD8+ effector T cells, presenting an early opportunity to destroy tumor cells that escape resection or ablative treatment as early metastases. The gene discussed is CD8A; the disease is lung carcinoma.